Lorenzo, R. B., Lorenzo, L. S. and González-Martín, A. (2017) “Will the carboplatin-paclitaxel-bevacizumab combination become the preferred option as the first line in advanced cervical cancer? A small experience from a single oncologic Center:  ”, Cancer Breaking News, 5(1), pp. 21–24. doi: 10.19156/cbn.2017.0035.